Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
J Assist Reprod Genet. 2020 Mar;37(3):539-548. doi: 10.1007/s10815-020-01718-5. Epub 2020 Mar 2.
The preimplantation genetic testing for monogenic defects (PGT-M) is a beneficial strategy for the patients suffering from a Mendelian disease, which could protect their offspring from inheriting the disease. The purpose of this study is to report the effectiveness of PGT-M based on karyomapping for three cases of dynamic mutation diseases with trinucleotide repeat expansion.
PGT-M was carried out on three couples, whose family members were diagnosed with Huntington's disease or spinocerebellar ataxias 2 or 12. The whole genome amplification was obtained using the multiple displacement amplification (MDA) method. Then, karyomapping was performed to detect the allele that is carrying the trinucleotide repeat expansion using single nucleotide polymorphism (SNP) linkage analyses, and the copy number variations (CNVs) of the embryos were also identified. Prenatal diagnosis was performed to validate the accuracy of PGT-M.
PGT-M was successfully performed on the three couples, and they accepted the transfers of euploid blastocysts without the relevant pathogenic allele. The clinical pregnancies were acquired and the prenatal diagnosis of the three families confirmed the effectiveness of karyomapping. The three born babies were healthy and free of the pathogenic alleles HTT, ATXN2, or PPP2R2B corresponding to Huntington's disease, spinocerebellar ataxias 2 or 12, respectively.
This study shows that karyomapping is a highly powerful and efficient approach for dynamic mutation detection in preimplantation embryos. In this work, we first report the birth of healthy babies that are free of the pathogenic gene for dynamic mutation diseases in patients receiving PGT-M by karyomapping.
单基因缺陷的胚胎植入前遗传学检测(PGT-M)是一种针对患有孟德尔疾病的患者的有益策略,它可以保护他们的后代免受疾病的遗传。本研究的目的是报告基于核型映射的 PGT-M 在三种三核苷酸重复扩展的动态突变疾病中的有效性。
对三对夫妇进行了 PGT-M 检测,这些夫妇的家庭成员被诊断患有亨廷顿病或脊髓小脑共济失调 2 型或 12 型。使用多重置换扩增(MDA)方法获得全基因组扩增。然后,通过单核苷酸多态性(SNP)连锁分析进行核型映射,以检测携带三核苷酸重复扩展的等位基因,并识别胚胎的拷贝数变异(CNVs)。进行产前诊断以验证 PGT-M 的准确性。
在三对夫妇中成功进行了 PGT-M,他们接受了没有相关致病等位基因的整倍体囊胚转移。获得了临床妊娠,对三个家庭的产前诊断证实了核型映射的有效性。三个出生的婴儿均健康,且没有与亨廷顿病、脊髓小脑共济失调 2 型或 12 型相对应的 HTT、ATXN2 或 PPP2R2B 致病基因。
本研究表明,核型映射是一种在胚胎植入前检测动态突变的非常强大和有效的方法。在这项工作中,我们首次报告了通过核型映射进行 PGT-M 的患者生育的健康婴儿,他们没有患有动态突变疾病的致病基因。